Expression and clinical significance of CacyBP/SIP in pancreatic cancer

Pancreatology

Volumn 8, Issue 4-5, 2008, Pages 470-477

  Chen, Xiong ^a   Han, Guohong ^a   Zhai, Huihong ^a   Zhang, Faming ^a   Wang, Jinbo ^a   Li, Xiaohua ^a   Huang, Sheng ^a   Wang, Xin ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CacyBP SIP; Carcinogenesis; Pancreatic cancer

Indexed keywords

BETA ACTIN; BINDING PROTEIN; CALCYCLIN; MESSENGER RNA; PARAFFIN; SIAH 1 INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CANCER; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 50549086503     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000151774     Document Type: Article

References (32)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer statistics. CA Cancer J Clin 2001;51:15-36.
2. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics. CA Cancer J Clin 2002;52:23-47.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics. CA Cancer J Clin 2003;53:5-26.
4. Chen R, Pan S, Brentnall TA, Aebersold R: Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteom 2005;4:523-533.
5. Singh M, Maitra A: Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007;7:9-19.
6. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M: Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head:25-year experience. World J Surg 2003;27:324-329.
7. Li D, Xie K, Wolff R, Abbruzzese JL: Pancreatic cancer. Lancet 2004;363:1049-1057.
8. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP: Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention. Pancreatology 2006;6:429-439.
9. Talamini G, Zamboni G, Salvia R, Capelli P, Sartori N, Casetti L, Bovo P, Vaona B, Falconi M, Bassi C, Scarpa A, Vantini I, Pederzoli P: Intraductal papillary mucinous neoplasms and chronic pancreatitis. Pancreatology 2006;6:626-634.
10. Filipek A, Wojda U: p30, a novel protein target of mouse calcyclin (S100A6). Biochem J 1996;320:585-587.
11. Filipek A, Kuznicki J: Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J Neurochem 1998;70:1793-1798.
12. Matsuzawa SI, Reed JC: Siah-1, SIP, and Ebi collaborate in a novel pathway for h-catenin degradation linked to p53 responses. Mol Cell 2001;7:915-926.
13. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, Matsunami N: Siah-1 mediates a novel h-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001;7:927-936.
14. Fukushima T, Zapata JM, Singha NC, et al: Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint. Immunity 2006;24:29-39.
15. Zhao Y, You H, Fan D, et al: Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002;85:211-218.
16. Shi Y, Hu W, Fan D, et al: Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP/SIP). Gastric Cancer 2004;7:160-166.
17. Cheng Y, Yan PF, Fan DM, et al: Prokaryotic expression of human calcyclin-binding protein and preparation of mouse polyclonal antibody against hCacyBP/SIP. Chin J Cell Mol Immunol 2004;20:206-209.
18. Zhai H, Shi Y, Fan D, et al: Establishment and characterization of calcyclin binding protein (CacyBP/SIP) monoclonal antibody. Hybridoma 2006;25:91-94.
19. Au KW, Kou CY, Woo AY, et al: Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J Cell Biochem 2006;98:555-566.
20. Yang YJ, Liu WM, Zhou JX, et al: Expression and hormonal regulation of calcyclin-binding protein (CacyBP/SIP) in the mouse uterus during early pregnancy. Life Sci 2006;78:753-760.
21. Xia ZB, Dai MS, Magoulas C, Broxmeyer HE, Lu L: Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. J Hematother Stem Cell Res 2000;9:651-658.
22. Pircher TJ, Geiger JN, Miller CP, Zhang D, Gaines P, Wojchowski DM: Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 2001;276:8995-9002.
23. 2+-dependent translocation of the calcyclin-binding protein in neurons and neuroblastoma NB-2a cells. J Biol Chem 2002;277:21103-21109.
24. Wu J, Tan X, Peng X, et al: Translocation and phosphorylation of calcyclin binding protein during retinoic acid-induced neuronal differentiation of neuroblastoma SH-SY5Y cells. J Biochem Mol Biol 2003;36:54-58.
25. Ning XX, Sun SR, Li Y, Gong WQ, Liu LL, Sun L, Liang J, Pan YL, Cheng Y, Wu KC, Fan DM: The effect of calcyclin binding protein on gastric cancer cell proliferation. Zhonghua Yi Xue Za Zhi 2006;6:3264-3268.
26. Sun S, Ning X, Liu J, Liu L, Chen Y, Han S, Zhang Y, Liang J, Wu K, Fan D: Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007;356:864-871.
27. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J: CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 2002;277:28848-28852.
28. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637-668.
29. Tonini GP, Casalaro A, Cara A, Di Martino D: Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res 1991;51:1733-1737.
30. Breen EC, Tang K: Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003;88:848-854.
31. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M: The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005;11:7785-7793.
32. Filipek A: S100A6 and CacyBP/SIP: two proteins discovered in Ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. Chemotherapy 2006;52:32-34.